Innate immunity against HIV: a priority target for HIV prevention research
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
http://link.springer.com/content/pdf/10.1186/1742-4690-7-84.pdf
Reference123 articles.
1. Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, Hu D, Tappero JW, Choopanya K, Group. BVE: Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis. 2006, 194: 1661-1671. 10.1086/508748.
2. Sekaly RP: The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. J Exp Med. 2008, 205: 7-12. 10.1084/jem.20072681.
3. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, et al: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009, 361: 2209-2220. 10.1056/NEJMoa0908492.
4. Rhee EG, Barouch DH: Harnessing innate immunity for HIV vaccine development. Clin Exp Immunol. 2009, 157: 174-180. 10.1111/j.1365-2249.2009.03928.x.
5. Harandi AM, Medaglini D, Shattock RJ, EUROPRISE. WGcb: Vaccine adjuvants: a priority for vaccine research. Vaccine. 2010, 28: 2363-2366. 10.1016/j.vaccine.2009.12.084.
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induction of the antiviral factors APOBEC3A and RSAD2 upon CCL2 neutralization in primary human macrophages involves NF-κB, JAK/STAT, and gp130 signaling;Journal of Leukocyte Biology;2024-05-27
2. HIV‐1 replication requires optimal activation of the unfolded protein response;FEBS Letters;2023-11-20
3. Violation of the vaginal microbiome and the risk of HIV infection in women;HIV Infection and Immunosuppressive Disorders;2023-04-30
4. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023
5. Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women;Seminars in Immunology;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3